Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ALPHARMA LISTS WARRANTS FOR TRADING ON NEW YORK STOCK EXCHANGE.


Fort Lee, N.J.--(BUSINESS WIRE)--October 9, 1995--ALPHARMA INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NYSE NYSE

See: New York Stock Exchange
:ALO) announced that effective today, Warrants to purchase approximately 2.45 million shares of the Company's Class A Common Stock have been listed for trading on the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
.

The Warrants have an exercise price of $2l.945 and are exercisable at any time prior to their expiration EXPIRATION. Cessation; end. As, the expiration of, a lease, of a contract, or statute.
     2. In general, the expiration of a contract puts an end to all the engagements of the parties, except to those which arise from the non- fulfillment of obligations created
 on January 3, 1999. On Friday, October 6, 1995, the closing price of the Company's common stock on the NYSE was $23.00.

These Warrants were issued to the shareholders of the Norwegian pharmaceutical company, Apothekernes Laboratorium A.S, in October 1994 as part of the consideration paid by ALPHARMA in connection with the transaction which combined the human pharmaceutical animal health businesses of that company with ALPHARMA. The closing price of the Company's common stock at the October 3, 1994 issuance of the Warrants was $17.13. Warrants to purchase a total of 3.6 million shares were issued at that time. However, by agreement, Warrants to purchase 2.45 million shares are being listed for trading now, with the balance of the Warrants to purchase approximately 1.15 million shares to be listed for trading in October 1997.

The Company currently has 21.6 million shares of its common stock outstanding. If all the Warrants issued are exercised before their January 1999 expiration date Expiration Date

The day on which an options or futures contract is no longer valid and, therefore, ceases to exist.

Notes:
The expiration date for all listed stock options in the U.S.
, 3.6 million additional shares will be issued with ALPHARMA receiving proceeds of approximately $79 million.

ALPHARMA is a multinational pharmaceutical company developing, manufacturing and marketing specialty generic and proprietary human pharmaceutical and animal health products. ALPHARMA is the largest manufacturer of generic liquid and topical pharmaceuticals in the U.S., has an established and growing market position in finished pharmaceuticals in Europe and the Far East, is a basic manufacturer of important specialty antibiotics Antibiotics Definition

Antibiotics may be informally defined as the subgroup of anti-infectives that are derived from bacterial sources and are used to treat bacterial infections.
, and is recognized worldwide as a leading provider of animal health feed additives for poultry poultry, domesticated fowl kept primarily for meat and eggs; including birds of the order Galliformes, e.g., the chicken, turkey, guinea fowl, pheasant, quail, and peacock; and natatorial (swimming) birds, e.g., the duck and goose.  and livestock, and vaccines for farmed fish.

CONTACT: Iris Daniels

ALPHARMA INC.

201/947-7774

Investor Contact:

Donna Stein/Courtney Levi

Morgen-Walke Associates, Inc.

212/850-5600

Press Contact:

Michelle Zawrothy

Morgen-Walke Associates, Inc.

212/850-5631
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 9, 1995
Words:351
Previous Article:Cabletron signs partnership agreement with Zenith; Move to expand marketshare in India.
Next Article:Encore accelerates paradigm shift; Intelligent Storage Controllers outfeature and outperform all fixed function DASD controllers.
Topics:



Related Articles
Allergan Ligand Retinoid Therapeutics, Inc. Subscription Offering Declared Effective By SEC.
Alpharma updates impact of business and industry trends on second half results.
Law Firm Kirby McInerney & Squire LLP Announces Class Action Lawsuit Against Alpharma, Inc.
Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against Alpharma, Inc.
Kirby McInerney & Squire LLP Announces Class Action Lawsuit Against Alpharma, Inc.
Law Firm Kirby McInerney & Squire LLP Announces Class Action Lawsuit Against Alpharma, Inc.
Law Firm of Barrack, Rodos & Bacine Announces Class Action Lawsuits Against Quintus, Knight Trading Group, Paradyne Networks, PSINet, Rent-Way and...
Barrack Rodos Files Class Action Lawsuit Against Alpharma, Inc.
Law Firm of Barrack, Rodos & Bacine Announces Class Action Lawsuits Against Knight Trading Group, Rent-Way and Alpharma.
Mylan Announces Sale of UDL Liquids.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles